Reardon Andrew is a corporate insider who has filed 17 SEC Form 4 transactions in the past 12 months across 0 companies. No open-market purchases were recorded; all transactions were sales or other dispositions. Insider activity is one signal among many — past performance does not guarantee future results.

Reardon Andrew

CLO

Latest Insider Transactions

Showing 10 of 35 transactions (past 365 days)

LGND
CLO
Sale
$141.3K
700 shares @ $201.90
Filed 2026-04-02Trade 2026-04-01
Ligand Pharmaceuticals Inc
LGND
CLO
Sale
$248.8K
1,238 shares @ $200.94
Filed 2026-04-02Trade 2026-04-01
Ligand Pharmaceuticals Inc
LGND
CLO
Sale
$260K
1,302 shares @ $199.72
Filed 2026-04-02Trade 2026-04-01
Ligand Pharmaceuticals Inc
LGND
CLO
Exercise Conversion
$0
5,000 shares @ $0.00
Filed 2026-04-02Trade 2026-04-01
Ligand Pharmaceuticals Inc
LGND
CLO
Sale
$91.5K
460 shares @ $198.85
Filed 2026-04-02Trade 2026-04-01
Ligand Pharmaceuticals Inc
LGND
CLO
Sale
$68.9K
337 shares @ $204.50
Filed 2026-04-02Trade 2026-04-01
Ligand Pharmaceuticals Inc
LGND
CLO
Exercise Conversion
$261.4K
5,000 shares @ $52.27
Filed 2026-04-02Trade 2026-04-01
Ligand Pharmaceuticals Inc
LGND
CLO
Sale
$195.7K
963 shares @ $203.22
Filed 2026-04-02Trade 2026-04-01
Ligand Pharmaceuticals Inc
LGND
CLO
Exercise Conversion
$0
5,000 shares @ $0.00
Filed 2026-03-06Trade 2026-03-04
Ligand Pharmaceuticals Inc
LGND
CLO
Sale
$300.9K
1,446 shares @ $208.12
Filed 2026-03-06Trade 2026-03-04
Ligand Pharmaceuticals Inc

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.